-
Nitrocefin Assays: Read the Resistance Signal
2026-08-24
Nitrocefin provides a rapid chromogenic readout of β-lactamase activity, but interpreting the signal requires attention to enzyme class, substrate specificity, and assay controls. This guide connects Nitrocefin workflow design with recent findings on the GOB-38 metallo-β-lactamase from Elizabethkingia anophelis.
-
Cefotaxime Workflows for Antimicrobial Resistance
2026-08-24
Cefotaxime supports more than routine susceptibility testing: it can connect beta-lactam activity, resistance phenotypes, plasmid transmission, and controlled bacterial infection models. This practical guide shows how to build reproducible assays around the product while avoiding common interpretation and stability errors.
-
HOBt: Stereochemical Control in Translational Synthesis
2026-08-23
HOBt is more than a conventional peptide coupling additive: it is a strategic tool for preserving stereochemical fidelity while medicinal chemistry teams move from carboxylic-acid building blocks to biologically tested amides. Using a glucagon receptor antagonist study as an anchor, this article connects HOBt-enabled chemistry with SAR quality, reproducibility, and translational decision-making.
-
MYC2–LBD40/42–CRL3BPM4 in Tomato Defense
2026-08-22
The reference study identifies a MYC2–LBD40/42–CRL3BPM4 module that fine-tunes tomato resistance to Botrytis cinerea by balancing defense activation with growth-related costs. Its combination of transcriptional, proteostatic, and genetic evidence provides a mechanistic framework for understanding how jasmonate signaling is restrained and reactivated during gray mold defense.
-
L-Alanyl-L-Glutamine in Reliable Cell Assays
2026-08-22
Learn how L-Alanyl-L-Glutamine (SKU B8228) can improve the control, preparation, and interpretation of cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical assay safeguards while distinguishing supported evidence from hypotheses requiring validation.
-
SmD2 Acetylation and PARP Inhibitor Sensitivity in HCC
2026-08-21
A 2024 Nature Communications study identifies SmD2 acetylation as a regulatory connection between core spliceosome function, BRCA1/FANC cassette exons, and PARP inhibitor sensitivity in hepatocellular carcinoma. The work supports combining spliceosome-directed epigenetic intervention with PARP inhibition, while also defining important limits for translating these findings to other tumor types.
-
COX-2, Ischemia, and Revascularization After Venom Injury
2026-08-20
This study shows that the cyclooxygenase-2 pathway has a time-dependent role in skeletal muscle injury caused by Bothrops asper venom: it protects the microvasculature during acute ischemia but can restrain later angiogenic signaling. The findings support temporally resolved inhibition studies that measure prostaglandins, CD31, VEGF, and matrix metalloproteinases rather than treating COX-2 as uniformly harmful or beneficial.
-
EGTA for Endothelial Calcium-Causality Studies
2026-08-20
EGTA and egtazic acid provide a selective way to interrogate extracellular calcium in endothelial inflammation models. This article connects EGTA assay design to the Piezo1–Talin1–YAP mechanism, emphasizing causal controls, handling limits, and interpretation rather than routine protocol repetition.
-
CHK1 Inhibition in Breast Cancer by ER/PR Status
2026-08-19
The reference study shows that CHK1 inhibition cannot be applied uniformly across breast cancer subtypes: it enhances adriamycin sensitivity in ER−/PR−/HER2− models but acts mainly as a single-agent treatment strategy in ER+/PR+/HER2− models. Its integrated use of clinical datasets, functional assays, and transcriptome analysis links these divergent responses to distinct cell-cycle and apoptosis pathways.
-
PP 1: Src Family Tyrosine Kinase Inhibitor
2026-08-19
A scenario-based guide to using PP 1 (Src family tyrosine kinase inhibitor), SKU A8215, in cell viability, proliferation, and signaling assays. It explains solvent control, concentration selection, orthogonal readouts, data interpretation, and practical criteria for selecting a reliable research-grade inhibitor.
-
ACE Inhibitors and Aminopeptidase Selectivity
2026-08-18
The reference study re-evaluated how bestatin and several metallopeptidase inhibitors affect the related cell-surface aminopeptidases AP-N, AP-A, and AP-W. Its head-to-head comparison showed that inhibitor selectivity is enzyme- and scaffold-dependent, with important implications for interpreting pharmacological experiments involving ACE inhibitors and zinc aminopeptidases.
-
Oligomycin A for Reliable Cell Assays
2026-08-18
Learn how Oligomycin A, SKU A5588, can clarify mitochondrial contributions to viability, proliferation, and cytotoxicity data. This scenario-based guide covers assay compatibility, solvent handling, metabolic adaptation, interpretation, and practical vendor-selection criteria.
-
Amiloride (MK-870) Ion Transport Workflow
2026-08-17
Use Amiloride (MK-870) as a time-controlled perturbation for epithelial sodium channel, PC2, uPAR, and uptake studies—not as a stand-alone proof of pathway identity. This workflow combines dose-response design, orthogonal readouts, and troubleshooting strategies for sodium channel research, cystic fibrosis research, hypertension research, and cellular endocytosis modulation.
-
Belinostat (PXD101) Workflow for Cancer Assays
2026-08-17
Belinostat (PXD101) combines potent pan-HDAC activity with measurable cell-cycle and growth effects in bladder and prostate cancer models. This workflow shows how to separate proliferation arrest from cell killing, improve dose-response reliability, and troubleshoot solubility, timing, and assay-readout problems.
-
Lithium, Rab11a, and Exosomal Wnt10a in Osteogenesis
2026-08-16
The reference study identifies a mechanism in which lithium enhances Rab11a-dependent secretion of exosomal Wnt10a from bone mesenchymal stem cells, thereby activating Wnt/β-catenin signaling and osteogenesis. Its comparison of lithium-conditioned exosomes and GelMA hydrogel delivery provides a framework for investigating engineered extracellular vesicles in bone repair.